Logo

UAMY

United States Antimony Corporation

UAMY

United States Antimony Corporation NYSE
$6.11 5.53% (+0.32)

Market Cap $710.41 M
52w High $19.71
52w Low $0.71
Dividend Yield 0%
P/E -152.75
Volume 4.42M
Outstanding Shares 116.27M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $8.702M $6.931M $-4.781M -54.938% $-0.04 $-4.501M
Q2-2025 $10.525M $2.818M $181.555K 1.725% $0.002 $297.562K
Q1-2025 $7M $2.014M $546.524K 7.807% $0.005 $639.462K
Q4-2024 $6.872M $2.573M $-882.919K -12.848% $-0.01 $-508.034K
Q3-2024 $2.572M $1.315M $-727.509K -28.284% $-0.007 $-787.689K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $19.609M $79.882M $8.131M $71.751M
Q2-2025 $6.967M $47.498M $9.992M $37.506M
Q1-2025 $18.746M $39.497M $6.905M $32.591M
Q4-2024 $18.172M $34.643M $6.042M $28.601M
Q3-2024 $12.991M $29.753M $4.626M $25.127M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-4.781M $-3.864M $-18.611M $35.136M $12.63M $-12.539M
Q2-2025 $181.555K $-627.695K $-16.523M $4.113M $-13.037M $-7.159M
Q1-2025 $546.524K $-1.729M $-862.011K $3.166M $574.821K $-2.592M
Q4-2024 $-1.078M $1.178M $-183.781K $4.209M $5.203M $970.6K
Q3-2024 $-683.097K $411.196K $241.747K $-32.068K $577.701K $338.86K

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Antimony
Antimony
$0 $0 $10.00M $10.00M
Precious Metals
Precious Metals
$0 $0 $0 $0
Zeolite
Zeolite
$0 $0 $0 $0

Five-Year Company Overview

Income Statement

Income Statement United States Antimony’s income statement shows a very small business that has been hovering around break‑even. Revenue has been fairly flat and modest for several years, with little sign of strong growth yet. Profitability has been weak: gross profit is thin, operating income has been close to zero, and net results have occasionally slipped into small losses. This points to a company still struggling to generate meaningful margins from its operations and heavily reliant on future volume and efficiency gains to improve earnings.


Balance Sheet

Balance Sheet The balance sheet is simple and relatively clean, but also small. The company holds a modest cash cushion and no financial debt, which reduces pressure from lenders and interest costs. Equity makes up essentially the entire capital structure, indicating it is funded by shareholders rather than borrowing. However, the overall asset base is limited, underscoring that this is a small‑scale operator with constrained financial resources. Any large expansion will likely require very careful capital planning or outside funding.


Cash Flow

Cash Flow Cash flow has been weak and flat, reflecting a business that is not yet generating strong cash from its core operations. Operating cash flow is around breakeven, which means the company has little internal cash to fund growth or weather downturns. Investment spending has been modest so far, which keeps cash needs down but also signals that major growth projects are only just ramping up. The key risk is that upcoming expansions and mine development will demand more cash than the business has historically produced, increasing execution and funding risk.


Competitive Edge

Competitive Edge Competitively, U.S. Antimony occupies a strategically important niche rather than competing on sheer size. It is the only fully integrated antimony producer in North America, with capabilities that run from mining to smelting to refined products. That positioning is reinforced by its role in the U.S. defense supply chain, including a long‑term agreement with a key government agency, and by its ability to produce military‑grade antimony materials. Its zeolite business adds some product and revenue diversification. The flip side is that the company is still small, operationally complex, and highly exposed to government policy, defense demand, and the specialized antimony market, all of which can shift.


Innovation and R&D

Innovation and R&D Innovation at U.S. Antimony is less about laboratory research and more about process know‑how and asset development. The company has deep metallurgical expertise in handling difficult antimony ores, flexible smelters that can take different feedstocks, and facilities that also recover precious metals. It is expanding its main smelter to dramatically raise capacity, restarting and modernizing domestic mines, and extending into other critical minerals such as tungsten alongside its long‑life zeolite assets. These moves could significantly strengthen the business if executed well, but they involve technical, regulatory, and capital risks, especially given the company’s limited historical cash generation.


Summary

Overall, United States Antimony is a strategically important but financially small materials company in transition. Its recent history shows low revenue, thin margins, and limited cash generation, but a clean balance sheet without debt. The company’s real strength lies in its unique position in the North American antimony supply chain, its close alignment with U.S. national security priorities, and a growing portfolio that includes zeolite and other critical minerals. The central question going forward is whether it can successfully scale production, deliver on government and commercial contracts, and turn its strong strategic position into durable, cash‑generating profitability without overstretching its limited financial base.